| 000 | 01629cam a2200349Ii 4500 | ||
|---|---|---|---|
| 001 | 9780429091742 | ||
| 008 | 180331t20162016fluacd obf 001 0 eng d | ||
| 020 |
_a9780429091742 _q(e-book : PDF) |
||
| 020 |
_z9789814669221 _q(hardback) |
||
| 024 | 7 |
_a10.1201/b19910 _2doi |
|
| 035 | _a(OCoLC)951461557 | ||
| 040 |
_aFlBoTFG _cFlBoTFG _erda |
||
| 050 | 4 |
_aHF5415.155 _b.H36 2016 |
|
| 082 | 0 | 4 |
_a658.5 _bH236 |
| 245 | 0 | 0 |
_aHandbook of clinical nanomedicine : _blaw, business, regulation, safety, and risk / _ceditor, Raj Bawa, MS, PhD, Patent Agent, Bawa Biotech LLC, Ashburn, Virginia, USA, Adjunct, Professor, Department of Biological Sciences, Rensselaer Polytechnic |
| 264 | 1 |
_aBoca Raton, Florida : _bCRC Press, _c[2016] |
|
| 264 | 4 | _c©2016 | |
| 300 | _a1 online resource | ||
| 336 |
_atext _2rdacontent |
||
| 337 |
_acomputer _2rdamedia |
||
| 338 |
_aonline resource _2rdacarrier |
||
| 490 | 0 |
_aPan Stanford series on nanomedicine ; _vvolume 2 |
|
| 505 | 0 | _asection 1. Law, business, and commercialization -- section 2. Regulatory issues and nanogovernance -- section 3. Health, safety, risk, and biological interactions -- section 4. Future implications, ethics, perspectives, and editorials. | |
| 650 | 0 |
_aProduct life cycle _vHandbooks, manuals, etc. _915246 |
|
| 650 | 0 |
_aNanomedicine _vHandbooks, manuals, etc. _911062 |
|
| 700 | 1 |
_aBawa, Raj, _eeditor. _912262 |
|
| 700 | 1 |
_aAudette, Gerald F., _eeditor. _912263 |
|
| 700 | 1 |
_aReese, Brian E., _eeditor. _915247 |
|
| 776 | 0 | 8 |
_iPrint version: _z9789814669221 |
| 856 | 4 | 0 |
_uhttps://www.taylorfrancis.com/books/9789814669238 _zClick here to view. |
| 942 | _cEBK | ||
| 999 |
_c70922 _d70922 |
||